AB0277 PREVALENCE OF HEPATITIS MARKERS IN PATIENTS TREATED WITH BIOLOGICAL DISEASE-MODIFYING ANTIRHEUMATIC DRUGS: RESULTS OF THE TUNISIAN REGISTRY BINAR
A. Fazaa(Hôpital Mongi Slim), A. Laatar(Hôpital Mongi Slim), S. Miladi(Hôpital Mongi Slim), S. Baklouti(Hopital Universitaire Hedi Chaker), I. Gharsallah(Military Hospital of Tunis), N. Bergaoui(Hospital Fatuma Bourguiba Monastir), M. Elleuch(Hôpital La Rabta), S. Kassab(Hôpital Mongi Slim), M.M. Kchir, L. Souabni(Hôpital Mongi Slim), S. Kochbati(Habib hospital Thameur), S. Chékili(Hôpital Mongi Slim), K. Ben Abdelghani(Hôpital Mongi Slim), K. Ouenniche(Hôpital Mongi Slim), Y. Mohamed(Military Hospital of Tunis), L. Abdelmoula(Hôpital Charles-Nicolle), E. Bouajina(Hôpital Farhat Hached), H. Boussaa(Tunis University)
Cited by 1
Related Papers
Behçet disease: epidemiology, classification criteria and treatment modalities
|Expert Review of Clinical Immunology|2024|15
Value of Hands Ultrasonography in the Differential Diagnosis Between Psoriatic Arthritis and Rheumatoid Arthritis
|Journal of Ultrasound in Medicine|2023|10
Progressive pseudorheumatoid dysplasia: A rare entity mimicking juvenile idiopathic arthritis
|Clinical Case Reports|2021|9
The first case of SARS-CoV-2-induced eosinophilic fasciitis
|Modern Rheumatology Case Reports|2023|8
A rare cause of lumbar nerve root compression: Extramedullary hematopoiesis in a patient with thalassemia major
|Clinical Case Reports|2021|5